These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
551 related items for PubMed ID: 26519764
21. Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents. Masi G, Perugi G, Toni C, Millepiedi S, Mucci M, Bertini N, Pfanner C. Bipolar Disord; 2006 Aug; 8(4):373-81. PubMed ID: 16879138 [Abstract] [Full Text] [Related]
22. Current and emerging pharmacotherapy for the treatment of adult attention deficit hyperactivity disorder (ADHD). Perugi G, Pallucchini A, Rizzato S, Pinzone V, De Rossi P. Expert Opin Pharmacother; 2019 Aug; 20(12):1457-1470. PubMed ID: 31112441 [Abstract] [Full Text] [Related]
25. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, Weiss M, Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520 [Abstract] [Full Text] [Related]
26. Pharmacotherapy of the Preschool ADHD Treatment Study (PATS) Children Growing Up. Vitiello B, Lazzaretto D, Yershova K, Abikoff H, Paykina N, McCracken JT, McGough JJ, Kollins SH, Greenhill LL, Wigal S, Wigal T, Riddle MA. J Am Acad Child Adolesc Psychiatry; 2015 Jul; 54(7):550-6. PubMed ID: 26088659 [Abstract] [Full Text] [Related]
28. Suicide risk reduction in youths with attention-deficit/hyperactivity disorder prescribed methylphenidate: A Taiwan nationwide population-based cohort study. Liang SH, Yang YH, Kuo TY, Liao YT, Lin TC, Lee Y, McIntyre RS, Kelsen BA, Wang TN, Chen VC. Res Dev Disabil; 2018 Jan; 72():96-105. PubMed ID: 29121517 [Abstract] [Full Text] [Related]
29. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC. BMC Pediatr; 2012 Jun 19; 12():78. PubMed ID: 22712630 [Abstract] [Full Text] [Related]
30. Dosage of methylphenidate and traumatic brain injury in ADHD: a population-based study in Taiwan. Liao YT, Yang YH, Kuo TY, Liang HY, Huang KY, Wang TN, Lee Y, McIntyre RS, Chen VC. Eur Child Adolesc Psychiatry; 2018 Mar 19; 27(3):279-288. PubMed ID: 28856464 [Abstract] [Full Text] [Related]
32. Risk of suicide attempts in adolescents and young adults with attention-deficit hyperactivity disorder: a nationwide longitudinal study. Huang KL, Wei HT, Hsu JW, Bai YM, Su TP, Li CT, Lin WC, Tsai SJ, Chang WH, Chen TJ, Chen MH. Br J Psychiatry; 2018 Apr 19; 212(4):234-238. PubMed ID: 29501070 [Abstract] [Full Text] [Related]
33. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study. Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Clin Ther; 2007 Jun 19; 29(6):1168-77. PubMed ID: 17692731 [Abstract] [Full Text] [Related]
37. Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. Lindemann C, Langner I, Kraut AA, Banaschewski T, Schad-Hansjosten T, Petermann U, Petermann F, Schreyer-Mehlhop I, Garbe E, Mikolajczyk RT. J Child Adolesc Psychopharmacol; 2012 Aug 19; 22(4):307-14. PubMed ID: 22856384 [Abstract] [Full Text] [Related]